site stats

Black diamond therapeutics investor relations

WebSep 12, 2024 · Sep 12, 2024, 08:17 ET. CAMBRIDGE, Mass., Sept. 12, 2024 /PRNewswire/ -- Black Diamond Therapeutics, Inc., a precision oncology medicine company pioneering the discovery and development of small ... WebSenior Director of Drug Metabolism and Pharmacokinetics. Black Diamond Therapeutics is a next-wave cancer precision medicine company. Black Diamond pioneered the development of selective medicines ...

Home • Black Diamond Therapeutics

WebApr 4, 2024 · Investor Relations Black ... Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small … WebFeb 27, 2024 · The Company’s proprietary Mutation-Allostery-Pharmacology, or MAP drug discovery engine, is designed to allow Black Diamond to analyze population-level genetic sequencing tumor data and validate ... cp to pc camera https://brain4more.com

BLACK DIAMOND THERAPEUTICS, INC. : Press releases BDTX

WebFeb 11, 2024 · A live webcast of the presentation can be accessed by visiting the investor relations section of the Company’s website, www.blackdiamondtherapeutics.com. A replay of the presentation will also be available and archived on the site for three weeks. About Black Diamond Therapeutics WebNov 9, 2024 · CAMBRIDGE, Mass. and NEW YORK, Nov. 09, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of ... WebMar 9, 2024 · The Company’s proprietary Mutation-Allostery-Pharmacology, or MAP drug discovery engine, is designed to allow Black Diamond to analyze population-level … cpt orif distal radius eaton

Black Diamond Therapeutics, Inc. Common Stock (BDTX)

Category:BLACK DIAMOND THERAPEUTICS, INC. : Press releases BDTX

Tags:Black diamond therapeutics investor relations

Black diamond therapeutics investor relations

Black Diamond Therapeutics to Present at the Piper Sandler …

WebApr 10, 2024 · The Investor Relations website contains information about Black Diamond Therapeutics, Inc.'s business for stockholders, potential investors, ... Black Diamond … WebBlack Diamond Therapeutics. 6,657 followers. 6mo. Black Diamond is pleased to announce the appointment of Sergey Yurasov, M.D., Ph.D., as Chief Medical Officer. Dr. Yurasov brings over 25 years of ...

Black diamond therapeutics investor relations

Did you know?

WebThe Investor Relations website contains information about Black Diamond Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts. WebApr 4, 2024 · Investor Relations Black ... Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies ...

WebBlack Diamond Therapeutics has raised a total of $197.1M in funding over 4 rounds. Their latest funding was raised on Dec 5, 2024 from a Series C round. Black Diamond Therapeutics is registered under the ticker NASDAQ:BDTX . Their stock opened with $19.00 in its Jan 29, 2024 IPO. Black Diamond Therapeutics is funded by 16 investors. WebNov 18, 2024 · Black Diamond Therapeutics is not a large company by global standards. It has a market capitalization of US$276m, which means it wouldn't have the attention of many institutional investors.

WebJul 7, 2024 · Black Diamond Therapeutics Insider Transactions Over The Last Year. In the last twelve months, the biggest single purchase by an insider was when Independent … WebSep 12, 2024 · Sep 12, 2024, 08:17 ET. CAMBRIDGE, Mass., Sept. 12, 2024 /PRNewswire/ -- Black Diamond Therapeutics, Inc., a precision oncology medicine company pioneering the discovery and development …

WebMar 9, 2024 · Black Diamond Therapeutics, Inc. Condensed Consolidated Balance Sheet Data (Unaudited) ... Stern Investor Relations (212) 362-1200 [email protected] [email protected]. Related Quotes.

WebFeb 27, 2024 · About Black Diamond. Black Diamond Therapeutics is a clinical-stage precision oncology medicine company focused on the development of MasterKey therapies that target families of oncogenic mutations in clinically validated targets. ... Stern Investor Relations (212) 362-1200 [email protected] [email protected]. Site - Shareholder … magnolia and rhodiolaWebFeb 27, 2024 · Black Diamond Therapeutics, Inc. February 27, 2024, 8:00 AM · 2 min read. Black Diamond Therapeutics, Inc. CAMBRIDGE, Mass. and NEW YORK, NY, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Black Diamond ... cp to saket distanceWebBLACK DIAMOND THERAPEUTICS, INC. : Press releases relating to BLACK DIAMOND THERAPEUTICS, INC. Investor relations Nasdaq: BDTX Nasdaq cpt opioid use disorder